CARY STREET PARTNERS INVESTMENT ADVISORY LLC
Position in ONC — BeOne Medicines Ltd.
CIK 1766904
RICHMOND, VA
Position in ONC
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$7,124
New position
Shares Held
25
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#241
of 282 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026CARY STREET PARTNERS INVESTMENT ADVISORY LLC holds $764,016 across 7 Biotechnology names. ONC ranks #5 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
688 | $428,990 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
555 | $275,679 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
478 | $35,600 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
173 | $13,539 | |
| 5 | ONC |
BeOne Medicines Ltd.
This page
|
25 | $7,124 | |
| 6 | FTRE |
Fortrea Holdings Inc.
|
134 | $2,331 | |
| 7 | PRTA |
Prothena Corp Public Ltd Co
|
77 | $753 |
All Filings in ONC
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,124 | 25 | Shares | Other | 2026-07-17 | |
| No filing history on record for this holder in this stock. | ||||||